InvestorsHub Logo

dshade

09/05/14 3:34 PM

#2984 RE: specular #2983

close above 8.50 and makes trip bottom

tomsylver

09/05/14 5:21 PM

#2985 RE: specular #2983

Look in the post:

Under terms of the license with TESARO, OPKO is eligible to receive up-front and milestone payments of up to $121 million.

now invest

09/08/14 1:02 PM

#2992 RE: specular #2983

Here is the kind of money OPK can get!!

Under the terms of OPKO’s agreement with TESARO (TSRO
Loading...
Loading...


), OPKO is eligible to receive payments of up to $121 million, including up-front and additional payments based on regulatory and commercialization milestones, including acceptance by FDA of the NDA. OPKO will receive double digit tiered-royalties on sales of rolapitant. In addition, TESARO (TSRO
Loading...
Loading...


) and OPKO will share future profits from the commercialization of rolapitant in Japan, and OPKO will have an option to market the products in Latin America.